TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Nordic Bioscience A/S
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
43,555
|
31,720
|
42,167 |
| Earnings before taxes |
13,619
|
5,771
|
18,572 |
| Total assets |
57,020
|
39,066
|
36,559 |
| Current assets |
46,403
|
27,421
|
25,195 |
| Current liabilities |
36,656
|
25,020
|
20,851 |
| Equity capital |
14,913
|
8,265
|
9,637 |
| - share capital |
1,340
|
1,342
|
1,345 |
| Employees (average) |
150
|
150
|
150 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
26.2%
|
21.2%
|
26.4% |
| Turnover per employee |
290
|
211
|
281 |
| Profit as a percentage of turnover |
31.3%
|
18.2%
|
44.0% |
| Return on assets (ROA) | |||
| Current ratio |
126.6%
|
109.6%
|
120.8% |
| Return on equity (ROE) |
91.3%
|
69.8%
|
192.7% |
| Change turnover |
11,865
|
-10,353
|
5,723 |
| Change turnover % |
37%
|
-25%
|
16% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.